Metabolic Engineering of Escherichia coli for Production of Polyhydroxyalkanoates with Hydroxyvaleric Acid Derived from Levulinic Acid

Doyun Kim,Sung Kuk Lee
DOI: https://doi.org/10.4014/jmb.2108.08016
2022-01-28
Journal of Microbiology and Biotechnology
Abstract:Polyhydroxyalkanoates (PHAs) are emerging as alternatives to plastics by replacing fossil fuels with renewable raw substrates. Herein, we present the construction of engineered <i>Escherichia coli</i> strains to produce short-chain-length PHAs (scl-PHAs), including the monomers 4-hydroxyvalerate (4HV) and 3-hydroxyvalerate (3HV) produced from levulinic acid (LA). First, an <i>E. coli</i> strain expressing genes (<i>lvaEDABC</i>) from the LA metabolic pathway of <i>Pseudomonas putida</i> KT2440 was constructed to generate 4HV-CoA and 3HV-CoA. Second, both PhaAB enzymes from <i>Cupriavidus necator</i> H16 were expressed to supply 3-hydroxybutyrate (3HB)-CoA from acetyl-CoA. Finally, PHA synthase (PhaC<sub>Cv</sub>) from <i>Chromobacterium violaceum</i> was introduced for the subsequent polymerization of these three monomers. The resulting <i>E. coli</i> strains produced four PHAs (w/w% of dry cell weight): 9.1 wt% P(4HV), 1.7 wt% P(3HV-<i>co</i>-4HV), 24.2 wt% P(3HB-<i>co</i>-4HV), and 35.6 wt% P(3HB-<i>co</i>-3HV-<i>co</i>-4HV).
biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?